Searched for
INDIA PHARMA IMPORTS
Globalisation 2.0, can it be furrowed home?Indian corporations are making bold strides abroad, with Essar establishing a massive $15 billion steel complex in Iowa. Notable companies ...- Govt extends import price curbs on two pharma raw materialsThe Directorate General of Foreign Trade has announced an extension of the minimum import price validity period. This extension will apply ...
- FIIs dump telecom for 8th straight month, outflows cross Rs 32,000 crore. Are stocks set for rebound?Foreign portfolio investors have dumped Indian telecom stocks for the eighth consecutive month, pulling out over Rs 32,000 crore in CY26. H...
- Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platformAnupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...
- Why is market falling today? Sensex slumps 700 points, Nifty below 22,600. 8 key factors rattling D-StreetStock market Down Today: On Tuesday, the Indian stock market faced a substantial downturn. This sharp decline came after a previous drop ex...
- Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speciality drugsIndian pharma stocks, including Sun Pharma and Aurobindo Pharma, are in focus after the US exempted India and 19 other countries from 100% ...
- India electronics firms get Rs 19,091 crore PLI incentives, investments cross Rs 20,580 croreElectronics manufacturing companies have received substantial incentives under the production-linked incentive scheme and attracted signifi...
- Nifty at key 23,000 support: Can bulls trigger a technical rebound?Nifty extended its losing streak to seven weeks, falling 0.88% to 23,140.50 as technical momentum remained bearish. The 23,000–23,200 zone ...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities suffered a sharp selloff, with Sensex plunging 1,248 points and Nifty falling 1.6% as US Treasury yields hit 19-year highs,...
- Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...
- Economy’s swell, but reputation? Why India’s next growth story depends on how the world sees itIndia’s long-term economic prospects remain strong despite short-term geopolitical, currency and capital-flow challenges. As the country’s ...
- Drug regulator warns against prolonged use of painkillers, antibioticsIndia’s drug regulator has warned against the indiscriminate, repeated or prolonged use of painkillers and antibiotics, citing risks includ...
- Sunil Singhania-led Abakkus Mutual Fund announces launch of its SIF platform FokkusAbakkus Mutual Fund, led by Sunil Singhania, has received SEBI approval to launch its Specialised Investment Fund (SIF) platform under the ...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- Why did market rise today? Sensex jumps 564 pts, Nifty closes above 23,400. 4 key factors driving the surgeIndian stock markets saw gains on Monday, with Sensex and Nifty rising. Cooling oil prices and strong global cues boosted investor sentimen...
- Aragen steps up investment in complex drug modalities; plans 500 KL new CDMO capacityAragen Life Sciences is increasing investments in complex drug modalities and manufacturing. The company plans to add significant small-mol...
- Dalal Street Week Ahead: Can Nifty defend the 23,000 support zone?Nifty enters the week in a corrective, range-bound setup, with 23,000–23,100 emerging as crucial support and 23,500 as the first resistance...
- Behind the Modi-Xi border thaw, India's dependence on Chinese imports, especially rare earths, keeps deepeningIndia faces a significant trade deficit with China, importing substantially more goods than it exports. Chinese firms offer superior price ...
- Cash-flow-based lending to become important for new-age sectors: SBI MDAs new industries emerge, cash-flow-based lending is poised to play a pivotal role in their growth. With traditional collateral often absen...
- Centre proposes easier norms for faster drug rolloutIndia's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug...
Load More
